Ernst‐Wilhelm Radü

Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression

Alberto Ascherio, Kassandra L. Munger, Rick White et al. · JAMA Neurology · 2014 · 512 citations

Medicine, Neurology, Pharmacotherapy +17

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

Ludwig Kappos, Mark S. Freedman, Chris H. Polman et al. · The Lancet · 2007 · 501 citations

Life Sciences, Neurology, Neuroimmunology +9

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

G. Francis, Richard AC Hughes, John King et al. · DIAL (Catholic University of Leuven) · 2001 · 472 citations

Pharmacy, Internal Medicine, Pharmacotherapy +8

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Ludwig Kappos, Mark S. Freedman, Chris H. Polman et al. · The Lancet Neurology · 2009 · 370 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +11

Regional Gray Matter Volume Abnormalities in the At Risk Mental State

Stefan Borgwardt, Anita Riecher‐Rössler, Paola Dazzan et al. · Biological Psychiatry · 2006 · 313 citations

Medicine, Neuroscience, Psychiatry +14